SNORD114-10: SNORD114-10 is a small nucleolar RNA (snoRNA) that is downregulated in metastatic omentum tissues in ovarian cancer (OC) [PMC5769367]. It is part of the SNORD114 cluster, which includes SNORD114-2 and SNORD114-11 [PMC5769367]. The expression of SNORD114-10 in OC samples is not correlated with age, FIGO division, pathological classification, or the presence of omental metastases [PMC5769367]. The downregulation of SNORD114-10 in metastatic omentum suggests that it may suppress the migration of ovarian tumor cells to secondary sites [PMC5769367]. This snoRNA may serve as a potential biomarker for OC metastasis [PMC6629867]. SNORD114-10 belongs to the family of small nucleolar RNAs and is specifically expressed in the brain [PMC8458545]. It has been implicated in neurodevelopmental disorders such as Prader-Willi and Angelman syndromes [PMC8458545]. In addition to OC, SNORD114-10 has also been found to be downregulated in metastatic ovarian cancer compared to primary tumors [PMC8677010]. Overall, the expression levels of SNORD114-10 are altered in various contexts and may play a role in tumor migration and neurodevelopmental disorders. Further studies are needed to understand its exact mechanisms and potential therapeutic implications.